Spurred by a recent report that popular testosterone treatments might raise men's heart risk, the Food and Drug Administration says it now plans a review of the therapies' safety.
FDA to probe risks of testosterone-boosting drugs
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.